Q12809 |
KCNH2_HUMAN |
Heart failure [ICD-11: BD10-BD1Z] |
Q12809 |
KCNH2_HUMAN |
Sleep-wake disorder [ICD-11: 7A00-7B2Z] |
Q12809 |
KCNH2_HUMAN |
Malaria [ICD-11: 1F40-1F45] |
Q12809 |
KCNH2_HUMAN |
Multiple sclerosis [ICD-11: 8A40] |
Q12809 |
KCNH2_HUMAN |
Pain [ICD-11: MG30-MG3Z] |
Q12809 |
KCNH2_HUMAN |
Cardiac arrhythmia [ICD-11: BC9Z] |
Q12809 |
KCNH2_HUMAN |
Angina pectoris [ICD-11: BA40] |
Q12809 |
KCNH2_HUMAN |
Genetic cardiac arrhythmia [ICD-11: BC65] |
Q12809 |
KCNH2_HUMAN |
Ovarian cancer [ICD-11: 2C73] |
P08684 |
CP3A4_HUMAN |
Solid tumour/cancer [ICD-11: 2A00-2F9Z] |
P08684 |
CP3A4_HUMAN |
Atopic eczema [ICD-11: EA80] |
P08684 |
CP3A4_HUMAN |
Anxiety disorder [ICD-11: 6B00-6B0Z] |
Q16236 |
NF2L2_HUMAN |
Ataxic disorder [ICD-11: 8A03] |
Q16236 |
NF2L2_HUMAN |
Breast cancer [ICD-11: 2C60-2C6Y] |
Q16236 |
NF2L2_HUMAN |
Glaucoma [ICD-11: 9C61] |
Q16236 |
NF2L2_HUMAN |
Lung cancer [ICD-11: 2C25] |
Q16236 |
NF2L2_HUMAN |
Macular degeneration [ICD-11: 9B75] |
Q16236 |
NF2L2_HUMAN |
Melanoma [ICD-11: 2C30] |
Q16236 |
NF2L2_HUMAN |
Mental/behavioural/neurodevelopmental disorder [ICD-11: 6E20-6E8Z] |
Q16236 |
NF2L2_HUMAN |
Pulmonary hypertension [ICD-11: BB01] |
Q16236 |
NF2L2_HUMAN |
Subarachnoid haemorrhage [ICD-11: 8B01] |
Q16236 |
NF2L2_HUMAN |
Urinary system clinical sympton [ICD-11: MF8Y] |
Q16236 |
NF2L2_HUMAN |
Non-alcoholic fatty liver disease [ICD-11: DB92] |
Q16236 |
NF2L2_HUMAN |
Alpha-1-antitrypsin deficiency [ICD-11: 5C5A] |
Q16236 |
NF2L2_HUMAN |
Motor neuron disease [ICD-11: 8B60] |
Q16236 |
NF2L2_HUMAN |
Multiple sclerosis [ICD-11: 8A40] |